Oct 2026· Molecular Genetics and Metabolism· Vol 149 3, pp.
110289
· 0 citations· 33 references
Medicine
TL;DR
This first-generation knowledgebase-level atlas quantifies reported disorder-level phenotype architecture rather than patient-level prevalence or natural history rather than patient-level prevalence or natural history and provides a scalable framework for phenotype standardization, diagnostic navigation, targeted curation, and future integration of age, variants, treatment, and real-world evidence.
Abstract
Background
Inherited metabolic disorders (IMDs) are classified by pathway and gene, but their multisystemic presentation complicates phenotype-first diagnosis.
Methods
Using a frozen IEMbase export, we analyzed expert-curated disorder-level phenotype annotations for 1737 IMDs across 21 phenotype domains, 24 disorder groups, and 122 subgroups. We quantified annotation frequency, multi-domain burden, and group-domain enrichment using binomial z-scores, with clustering, principal component analysis, and bipartite networks for higher-order structure. Primary analyses were age-independent; age coverage was assessed exploratorily.
Results
Disorders involved a mean of 4.01 ± 2.54 phenotypic categories. Neurologic involvement was annotated in 70.5%, followed by Eye (38.3%) and Other (34.7%). Enrichment identified hotspots, including endocrine metabolic disorders → Endocrine (z ≈ 12.6) and congenital disorders of glycosylation → Dysmorphic/Skeletal (z ≈ 10.3/8.0), with glycosylation and mitochondrial phenotype clouds. Age-specific information was available for 98.7% of disorders in at least one interval, but only 28.9% spanned all five.
Conclusions
This first-generation knowledgebase-level atlas quantifies reported disorder-level phenotype architecture rather than patient-level prevalence or natural history. It provides a scalable framework for phenotype standardization, diagnostic navigation, targeted curation, and future integration of age, variants, treatment, and real-world evidence.
Objective: 22q11.2 deletion syndrome (22q11DS) is the leading genetic cause of palatal anomalies, presenting a heterogeneous spectrum of clinical manifestations that complicates early diagnosis. No study has systematically investigated the co-occurrence of symptoms spanning cardiovascular, neuropsychiatric, craniofacia...
L. A. Azevedo Soares, D. Domeneghetti de Francisco, V. Gil-da-Silva-Lopes et al.· medRxiv· 0 citations
Autism spectrum disorder (ASD) is a systemic multi-organ condition characterized by profound biological heterogeneity. Clinical management currently faces a bottleneck due to reliance on subjective behavioral phenotyping rather than objective molecular markers. This review synthesizes breakthroughs in ASD diagnostics,...
This framework resolves overlapping and clinically ambiguous phenotypes, improves separation of progressive and seronegative cases, and reveals DN as a heterogeneous entity that is metabolically distinct from MS while demonstrating closer proximity to MOGAD.
Yi-Nuo Zang, Daniel C. Anthony, T. Yeo et al.· Journal of Neuroinflammation· 0 citations
Using KIF1A-associated neurological disorder (KAND) as a model system, single-molecule biophysical phenotyping of 91 pathogenic variants with longitudinal clinical characterization of 343 patients offers a prognostic tool and a stratification strategy for clinical trials.
Lu Rao, Wen-Xing Li, Jessica Waxler et al.· medRxiv· 0 citations
Neurodevelopmental disorders (NDDs) are clinically and genetically heterogeneous, and evidence linking additional genes to disease evolves rapidly. We developed SysNDD, an open-access, expert-curated resource that represents distinct gene-inheritance-disease associations as entities with standardized confidence, phenot...
B. Popp, Simon P. Früh, M. Altay et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.